Funded Startups in Barcelona
The 50 most recent funded rounds from Barcelona span May through late November 2025, with AI and biotechnology emerging as the two dominant verticals.
The 50 most recent funded rounds from Barcelona span May through late November 2025, with AI and biotechnology emerging as the two dominant verticals. The largest single deal is Splice Bio's $135M Series B in June 2025, followed by Aily Labs at $80M and Amenitiz at $45M Series B — both closing in November 2025. At least ten companies in the dataset operate in biotechnology, including Seqera ($26M Series B), Minoryx Therapeutics ($31M), Aortyx ($16M Series A), and Integra Therapeutics ($13M Seed), reflecting a mature life-sciences cluster alongside the city's software activity.
Seed rounds are the most common stage, roughly 15 of the 50 entries, and several carry growth-stage-sized checks: THEKER Robotics and Murphy AI each raised $13–18M at seed in July 2025. Pre-seed activity remains steady through Q4 2025, with Afori ($5M), Kabilio ($4M), and Uxia ($1M) among seven rounds at that stage. At least seven entries carry undisclosed amounts, including ClikBy, Wecaria, and SquarePoint.
Most recent rounds
50 shownRelated listings
Frequently asked
What are the largest recent rounds raised by Barcelona startups?
The three largest disclosed rounds in this dataset are Splice Bio's $135M Series B (June 2025), Aily Labs' $80M venture round (November 2025), and Amenitiz's $45M Series B (November 2025). Minoryx Therapeutics ($31M), Seqera ($26M Series B), and HolaCamp ($24M) also rank among the largest. All six of these were closed between May and November 2025.
Which sectors account for the most funding activity in Barcelona right now?
Biotechnology and artificial intelligence are the two most active verticals across these 50 rounds. At least 10 companies are in biotechnology — including Splice Bio, Seqera, Integra Therapeutics, Minoryx Therapeutics, and Oryzon Genomics — while AI appears in the sector tags of at least 12 companies, ranging from Aily Labs and Murphy AI to Remuner, Biorce, and Bookline.
What funding stages are Barcelona startups most commonly raising at?
Seed is the most frequent stage, accounting for roughly 15 of the 50 entries. Pre-seed rounds make up at least seven entries, including Afori ($5M), Kabilio ($4M), and METLY ($780K). Four Series B rounds appear — Splice Bio, Amenitiz, Aistech, and Seqera — and three Series A rounds: Dost ($8M), Bookline ($4M), and Aortyx ($16M).
Are any of the Barcelona seed rounds unusually large?
Several are. THEKER Robotics raised $18M at seed in July 2025, Murphy AI closed $13M at seed in the same month, and Integra Therapeutics raised $13M at seed in September 2025. These figures sit at the upper end of what is typically considered seed-stage capital, driven largely by deep-tech and biotech companies in the dataset.
How much of the funding activity shown has undisclosed amounts?
At least seven of the 50 entries list undisclosed round sizes, including ClikBy, Wecaria, SquarePoint, Ability Pharmaceuticals, SCUFF, Tree-Nation, and Saesco Medical. Among companies that did disclose, round sizes range from $120K (Tennders, CeleBreak) to $135M (Splice Bio), with the majority of disclosed amounts falling between $1M and $20M.
How recent and concentrated is the Barcelona funding activity in this dataset?
The 50 rounds span from May 2025 through late November 2025, a roughly seven-month window. November 2025 alone accounts for at least eight rounds, including Hair Up Laser, Uxia, Dost, The Blue Box Biomedical Solutions, Amenitiz, Aily Labs, Kabilio, and ClikBy, suggesting sustained deal flow into the back half of 2025.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.